# OnCo record paper-destiny-gastric01-nejm-2020 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-destiny-gastric01-nejm-2020/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-destiny-gastric01-nejm-2020" ;
  schema:name "DESTINY-Gastric01: trastuzumab deruxtecan in previously treated HER2-positive gastric cancer"@en ;
  schema:description "Trastuzumab deruxtecan shrank tumours in half of patients with HER2-positive gastric cancer that had progressed after trastuzumab, compared with 14 percent on chemotherapy, and lengthened survival by over four months."@en ;
  schema:url <https://onco.cc/key-papers/paper-destiny-gastric01-nejm-2020/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa2004413>, <https://pubmed.ncbi.nlm.nih.gov/32469182/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa2004413> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "Shitara K, Bang YJ, Iwasa S, et al." ;
  onco:cancers <https://onco.cc/cancers/gastric-her2-positive/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/trastuzumab-deruxtecan/> ;
  onco:trials <https://onco.cc/trials/destiny-gastric01/>, <https://onco.cc/trials/destiny-gastric02/> ;
  onco:journals <https://onco.cc/journals/nejm/> .